-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Looking at the domestic pharmaceutical equipment market in the past two years, we are delighted to see some new changes
.
Some domestic pharmaceutical machine products are no longer blocked by local pharmaceutical companies as in the past, especially since the epidemic, in the case of delayed delivery of imported equipment, pharmaceutical companies are facing challenges in production transformation and capacity expansion
.
In this context, many pharmaceutical companies have set their sights on domestic products, and many powerful local pharmaceutical companies have received a large number of new orders, and their performance has grown rapidly
.
Because of the timely delivery, convenient maintenance, and high cost performance, these pharmaceutical equipment are gradually being accepted by pharmaceutical companies and are expected to continue to deepen cooperation
.
At the same time, domestic pharmaceutical equipment is constantly breaking through the bottleneck.
While meeting the domestic market demand, it gradually goes to the overseas market and "connects" with international customers, such as Chutian, Tofflon and other pharmaceutical machinery companies in their international business since 2020.
The growth is obvious, adding a nice touch to the entire performance report card
.
Pharmaceutical equipment (picture source: Pharmaceutical Network) The pharmaceutical equipment industry plays a new chapter of development Since 2021, many securities institutions have pointed out that the pharmaceutical equipment industry is gradually breaking away from the cycle and ushering in growth, and a new movement of development has been played
.
At present, the market scale of China's pharmaceutical equipment industry is about 130 billion yuan
.
With the acceleration of the transformation and upgrading of the downstream pharmaceutical industry, the increase of investment in fixed assets by pharmaceutical companies, and the accelerated import substitution of domestic pharmaceutical equipment, China's pharmaceutical equipment market has a larger space
.
According to Guosen Securities' forecast, by 2024, this market is expected to reach 174 billion yuan
.
In the face of the blue ocean of the new market, many domestic pharmaceutical equipment companies have already sensed the opportunity.
In order to accelerate the increase in market share, they continue to practice their internal skills and improve their own skills through mergers and acquisitions, increasing investment in research and development, and focusing on talent team training.
Competitiveness and dominant position
.
Innovation as the main theme This year is the first year of the "15 years", and the plan is to elevate "innovation-driven development" to a new historical height
.
And innovation has also become a major theme in the development of the pharmaceutical equipment industry
.
At the recent China International Pharmaceutical Equipment Exhibition, many domestic pharmaceutical equipment manufacturers mentioned the key word "innovation", taking innovation as a major driving force for improving competitiveness and sustainable development of the company
.
It can be said that the awareness of innovation has become more and more important in the minds of Pharmaceutical Machines, and it has also been paid more and more attention
.
For example, a manufacturer of checkweigher equipment pointed out that in the past, soft granule bags used belt checkweighers, and the accuracy was only 0.
1g, and there was an obvious false rejection rate
.
Faced with this problem, the company team has innovatively designed a variety of solutions to change the way the product moves on the weighing platform, so that the checkweighing accuracy reaches 0.
02g~0.
005g, which greatly improves the accuracy and checkweighing speed, occupying this area.
A dominant position in the market
.
In addition, in order to promote product innovation, the company’s annual R&D costs account for more than 10% of operating income, and a reward system has been established to encourage invention and innovation and algorithm optimization, and give developers time and funds to actually verify new solutions and new structures.
.
There are also pharmaceutical machinery companies that are committed to the field of material crushing.
In an interview with Pharmaceutical.
com, 2018-2021 is the company’s technological revolution.
In the context of the company’s rapid development, in order to better serve customers, technological innovation has also been mentioned.
To the front
.
To this end, the company hired a team of experts to carry out research and breakthroughs in the crushing fluid, so that the entire fluid structure has been improved
.
In the future, the company will also attach great importance to innovation and win with technology
.
Concluding Remarks Facing the new situation, a new chapter of innovation in the pharmaceutical equipment industry has opened.
With the efforts of policies, industry enterprises and other parties, it is believed that domestic pharmaceutical equipment will accelerate the transformation from low-end to mid-to-high-end in the future to meet the new needs of modern pharmaceutical companies.
At the same time, it will also accelerate the pace of domestic substitution in the high-end field, and promote the development of the domestic pharmaceutical machinery industry to a new level
.
.
Some domestic pharmaceutical machine products are no longer blocked by local pharmaceutical companies as in the past, especially since the epidemic, in the case of delayed delivery of imported equipment, pharmaceutical companies are facing challenges in production transformation and capacity expansion
.
In this context, many pharmaceutical companies have set their sights on domestic products, and many powerful local pharmaceutical companies have received a large number of new orders, and their performance has grown rapidly
.
Because of the timely delivery, convenient maintenance, and high cost performance, these pharmaceutical equipment are gradually being accepted by pharmaceutical companies and are expected to continue to deepen cooperation
.
At the same time, domestic pharmaceutical equipment is constantly breaking through the bottleneck.
While meeting the domestic market demand, it gradually goes to the overseas market and "connects" with international customers, such as Chutian, Tofflon and other pharmaceutical machinery companies in their international business since 2020.
The growth is obvious, adding a nice touch to the entire performance report card
.
Pharmaceutical equipment (picture source: Pharmaceutical Network) The pharmaceutical equipment industry plays a new chapter of development Since 2021, many securities institutions have pointed out that the pharmaceutical equipment industry is gradually breaking away from the cycle and ushering in growth, and a new movement of development has been played
.
At present, the market scale of China's pharmaceutical equipment industry is about 130 billion yuan
.
With the acceleration of the transformation and upgrading of the downstream pharmaceutical industry, the increase of investment in fixed assets by pharmaceutical companies, and the accelerated import substitution of domestic pharmaceutical equipment, China's pharmaceutical equipment market has a larger space
.
According to Guosen Securities' forecast, by 2024, this market is expected to reach 174 billion yuan
.
In the face of the blue ocean of the new market, many domestic pharmaceutical equipment companies have already sensed the opportunity.
In order to accelerate the increase in market share, they continue to practice their internal skills and improve their own skills through mergers and acquisitions, increasing investment in research and development, and focusing on talent team training.
Competitiveness and dominant position
.
Innovation as the main theme This year is the first year of the "15 years", and the plan is to elevate "innovation-driven development" to a new historical height
.
And innovation has also become a major theme in the development of the pharmaceutical equipment industry
.
At the recent China International Pharmaceutical Equipment Exhibition, many domestic pharmaceutical equipment manufacturers mentioned the key word "innovation", taking innovation as a major driving force for improving competitiveness and sustainable development of the company
.
It can be said that the awareness of innovation has become more and more important in the minds of Pharmaceutical Machines, and it has also been paid more and more attention
.
For example, a manufacturer of checkweigher equipment pointed out that in the past, soft granule bags used belt checkweighers, and the accuracy was only 0.
1g, and there was an obvious false rejection rate
.
Faced with this problem, the company team has innovatively designed a variety of solutions to change the way the product moves on the weighing platform, so that the checkweighing accuracy reaches 0.
02g~0.
005g, which greatly improves the accuracy and checkweighing speed, occupying this area.
A dominant position in the market
.
In addition, in order to promote product innovation, the company’s annual R&D costs account for more than 10% of operating income, and a reward system has been established to encourage invention and innovation and algorithm optimization, and give developers time and funds to actually verify new solutions and new structures.
.
There are also pharmaceutical machinery companies that are committed to the field of material crushing.
In an interview with Pharmaceutical.
com, 2018-2021 is the company’s technological revolution.
In the context of the company’s rapid development, in order to better serve customers, technological innovation has also been mentioned.
To the front
.
To this end, the company hired a team of experts to carry out research and breakthroughs in the crushing fluid, so that the entire fluid structure has been improved
.
In the future, the company will also attach great importance to innovation and win with technology
.
Concluding Remarks Facing the new situation, a new chapter of innovation in the pharmaceutical equipment industry has opened.
With the efforts of policies, industry enterprises and other parties, it is believed that domestic pharmaceutical equipment will accelerate the transformation from low-end to mid-to-high-end in the future to meet the new needs of modern pharmaceutical companies.
At the same time, it will also accelerate the pace of domestic substitution in the high-end field, and promote the development of the domestic pharmaceutical machinery industry to a new level
.